Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Work In Process (2022 - 2026)

HeartSciences' Work In Process history spans 5 years, with the latest figure at $21741.0 for Q1 2026.

  • For Q1 2026, Work In Process changed 0.0% year-over-year to $21741.0; the TTM value through Jan 2026 reached $21741.0, changed 0.0%, while the annual FY2025 figure was $21741.0, 0.0% changed from the prior year.
  • Work In Process reached $21741.0 in Q1 2026 per HSCS's latest filing, roughly flat from $21741.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $21741.0 in Q2 2022 to a low of $21741.0 in Q2 2022.
  • Average Work In Process over 5 years is $21741.0, with a median of $21741.0 recorded in 2022.
  • The largest YoY upside for Work In Process was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
  • A 5-year view of Work In Process shows it stood at $21741.0 in 2022, then changed by 0.0% to $21741.0 in 2023, then changed by 0.0% to $21741.0 in 2024, then changed by 0.0% to $21741.0 in 2025, then changed by 0.0% to $21741.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Work In Process are $21741.0 (Q1 2026), $21741.0 (Q4 2025), and $21741.0 (Q3 2025).